long-acting beta-agonist and inhaled corticosteroid (LABA-ICS) combination therapy after hospital discharge in older adults with COPD. ... well as standardized practices to prevent medication errors at hospital discharge in the COPD population,” the
A 63-year-old man is admitted to the ICU for an exacerbation of COPD. ... The anti-inflammatory effects of simvastatin were previously believed to reduce exacerbations in COPD.
Most patients with exacerbations of COPD are usually easily oxygenated on low levels of inspired oxygen. ... Anticholinergic agents in COPD are especially useful when combined with short-acting or long-acting β.
A systematic review of 68 randomized controlled trials found scant evidence supporting other pharmacologic interventions to treat adults with mild to severe exacerbation of chronic obstructive pulmonary disease (COPD). ... Antibiotics and systemic
She has severe COPD requiring long-term oxygen therapy. Her baseline arterial P. ... Adding ipratropium bromide is unlikely to reverse the nocturnal hypoxemia associated with COPD.
Patients with eosinophilic exacerbations are clinically indistinguishable from other patients with severe COPD exacerbations, but they may respond more rapidly to corticosteroid treatment. ... A higher eosinophil count is associated with shorter length
Researchers searched MEDLINE and EMBASE from 1974 to October 2015 and included 7 studies of patients with unexplained COPD exacerbations in their review. ... COPD exacerbations, can increase venous thromboembolism risk; and pulmonary embolism could
They were also more likely to be prescribed calcium-channel blockers and diuretics and took more COPD medications at baseline. ... The results suggest that MI patients with COPD may benefit from beta-blockers, the study authors concluded.
Eosinophil-guided therapy was noninferior to standard care with systemic corticosteroids for acute exacerbation of chronic obstructive pulmonary disease (COPD) in a recent small study. ... Patients were eligible if they were at least 40 years of age, had
Acetazolamide may not significantly reduce mechanical ventilation time in COPD patients, study finds
The double-blind DIABOLO trial, conducted from October 2011 through July 2014 in 15 ICUs in France, studied 380 adult patients with a history of chronic obstructive pulmonary disease (COPD) who ... The double-blind DIABOLO trial, conducted from October